FDA Approved: BUPHENYL — Supplemental Application (Horizon Therapeutics USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for BUPHENYL (sodium phenylbutyrate) submitted by Horizon Therapeutics USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ornithine Transcarbamylase Deficiency
• Urea Cycle Disorders

Drugs mentioned

• BUPHENYL (Sodium phenylbutyrate)

Snippet

SUPPL AP for BUPHENYL (SODIUM PHENYLBUTYRATE)